247 related articles for article (PubMed ID: 24100612)
1. Blood volatile compounds as biomarkers for colorectal cancer.
Wang C; Li P; Lian A; Sun B; Wang X; Guo L; Chi C; Liu S; Zhao W; Luo S; Guo Z; Zhang Y; Ke C; Ye G; Xu G; Zhang F; Li E
Cancer Biol Ther; 2014 Feb; 15(2):200-6. PubMed ID: 24100612
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive detection of colorectal cancer by analysis of exhaled breath.
Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E
Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062
[TBL] [Abstract][Full Text] [Related]
3. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
[TBL] [Abstract][Full Text] [Related]
4. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
[TBL] [Abstract][Full Text] [Related]
5. [Measurement of exhaled volatile organic compounds in lung cancer patients].
Lu CR; Hu YJ; Chen EG; Qiu YH; Ying KJ
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):104-8. PubMed ID: 20367949
[TBL] [Abstract][Full Text] [Related]
6. Exhaled breath volatile biomarker analysis for thyroid cancer.
Guo L; Wang C; Chi C; Wang X; Liu S; Zhao W; Ke C; Xu G; Li E
Transl Res; 2015 Aug; 166(2):188-95. PubMed ID: 25666355
[TBL] [Abstract][Full Text] [Related]
7. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
8. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
9. Breath Fingerprint of Colorectal Cancer Patients Based on the Gas Chromatography-Mass Spectrometry Analysis.
Kononova E; Mežmale L; Poļaka I; Veliks V; Anarkulova L; Vilkoite I; Tolmanis I; Ļeščinska AM; Stonāns I; Pčolkins A; Mochalski P; Leja M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338911
[TBL] [Abstract][Full Text] [Related]
10. Exploratory study on noninvasive biomarker of silicosis in exhaled breath by solid-phase microextraction-gas chromatography-mass spectrometry analysis.
Yi Z; Dong S; Wang X; Xu M; Li Y; Xie L
Int Arch Occup Environ Health; 2023 Aug; 96(6):857-868. PubMed ID: 37067574
[TBL] [Abstract][Full Text] [Related]
11. Oxidative Stress Biomarkers in Exhaled Breath of Workers Exposed to Crystalline Silica Dust by SPME-GC-MS.
Jalali M; Zare Sakhvidi MJ; Bahrami A; Berijani N; Mahjub H
J Res Health Sci; 2016; 16(3):153-161. PubMed ID: 27840344
[TBL] [Abstract][Full Text] [Related]
12. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB
Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255
[TBL] [Abstract][Full Text] [Related]
13. Release of volatile organic compounds (VOCs) from colorectal cancer cell line LS174T.
Liu M; Li Y; Wang G; Guo N; Liu D; Li D; Guo L; Zheng X; Yu K; Yu K; Wang C
Anal Biochem; 2019 Sep; 581():113340. PubMed ID: 31226253
[TBL] [Abstract][Full Text] [Related]
14. Global Plasma Profiling for Colorectal Cancer-Associated Volatile Organic Compounds: a Proof-of-Principle Study.
Kim S; Yin X; Prodhan MAI; Zhang X; Zhong Z; Kato I
J Chromatogr Sci; 2019 May; 57(5):385-396. PubMed ID: 30796770
[TBL] [Abstract][Full Text] [Related]
15. Screening for volatile biomarkers of colorectal cancer by analyzing breath and fecal samples using thermal desorption combined with GC-MS (TD-GC-MS).
Śmiełowska M; Ligor T; Kupczyk W; Szeliga J; Jackowski M; Buszewski B
J Breath Res; 2023 Jul; 17(4):. PubMed ID: 37406626
[TBL] [Abstract][Full Text] [Related]
16. Determination of volatile organic compounds in SW620 colorectal cancer cells and tumor-bearing mice.
Wang G; Li Y; Liu M; Guo N; Han C; Liu D; Li D; Yang M; Peng Y; Liu Y; Yu K; Wang C
J Pharm Biomed Anal; 2019 Apr; 167():30-37. PubMed ID: 30738241
[TBL] [Abstract][Full Text] [Related]
17. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
18. Application of an artificial neural network model for selection of potential lung cancer biomarkers.
Ligor T; Pater Ł; Buszewski B
J Breath Res; 2015 May; 9(2):027106. PubMed ID: 25944812
[TBL] [Abstract][Full Text] [Related]
19. Breath testing as potential colorectal cancer screening tool.
Amal H; Leja M; Funka K; Lasina I; Skapars R; Sivins A; Ancans G; Kikuste I; Vanags A; Tolmanis I; Kirsners A; Kupcinskas L; Haick H
Int J Cancer; 2016 Jan; 138(1):229-36. PubMed ID: 26212114
[TBL] [Abstract][Full Text] [Related]
20. Perylene diimide-POSS network for semi selective solid-phase microextraction of lung cancer biomarkers in exhaled breath.
Soufi G; Bagheri H; Yeganeh Rad L; Minaeian S
Anal Chim Acta; 2022 Mar; 1198():339550. PubMed ID: 35190135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
